ALPS Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,045
| Closed | -$409K | – | 973 |
|
|
2021
Q4 | $409K | Sell |
4,045
-76
| -2% | -$7.58K | ﹤0.01% | 636 |
|
|
2021
Q3 | $380K | Buy |
4,121
+710
| +21% | +$68.3K | ﹤0.01% | 616 |
|
|
2021
Q2 | $349K | Hold |
3,411
| – | – | ﹤0.01% | 704 |
|
|
2021
Q1 | $333K | Sell |
3,411
-27
| -0.8% | -$2.46K | ﹤0.01% | 699 |
|
|
2020
Q4 | $265K | Sell |
3,438
-104
| -3% | -$8.04K | ﹤0.01% | 788 |
|
|
2020
Q3 | $261K | Sell |
3,542
-503
| -12% | -$40.4K | ﹤0.01% | 705 |
|
|
2020
Q2 | $297K | Sell |
4,045
-450
| -10% | -$35.3K | ﹤0.01% | 559 |
|
|
2020
Q1 | $260K | Buy |
+4,495
| New | +$313K | ﹤0.01% | 539 |
|
|
2019
Q3 | – | Sell |
-4,073
| Closed | -$324K | – | 992 |
|
|
2019
Q2 | $324K | Sell |
4,073
-216
| -5% | -$17.1K | ﹤0.01% | 830 |
|
|
2019
Q1 | $360K | Buy |
+4,289
| New | +$448K | ﹤0.01% | 849 |
|
|
2018
Q1 | – | Sell |
-8,141
| Closed | -$603K | – | 995 |
|
|
2017
Q4 | $603K | Hold |
8,141
| – | – | ﹤0.01% | 396 |
|
|
2017
Q3 | $470K | Sell |
8,141
-208
| -2% | -$12.3K | ﹤0.01% | 625 |
|
|
2017
Q2 | $535K | Buy |
8,349
+22
| +0.3% | +$1.36K | ﹤0.01% | 440 |
|
|
2017
Q1 | $480K | Buy |
8,327
+2,123
| +34% | +$127K | ﹤0.01% | 521 |
|
|
2016
Q4 | $380K | Buy |
6,204
+60
| +1% | +$3.91K | ﹤0.01% | 626 |
|
|
2016
Q3 | $425K | Sell |
6,144
-576
| -9% | -$38K | ﹤0.01% | 442 |
|
|
2016
Q2 | $374K | Sell |
6,720
-496
| -7% | -$29.9K | ﹤0.01% | 513 |
|
|
2016
Q1 | $438K | Buy |
7,216
+202
| +3% | +$11.9K | ﹤0.01% | 440 |
|
|
2015
Q4 | $448K | Sell |
7,014
-200
| -3% | -$13K | ﹤0.01% | 551 |
|
|
2015
Q3 | $4.83K | Sell |
7,214
-3,386
| -32% | -$239K | 0.01% | 463 |
|
|
2015
Q2 | $724K | Buy |
10,600
+164
| +2% | +$10.4K | 0.01% | 234 |
|
|
2015
Q1 | $580K | Sell |
10,436
-4,046
| -28% | -$207K | ﹤0.01% | 229 |
|
|
2014
Q4 | $743K | Sell |
14,482
-1,944
| -12% | -$95.5K | 0.01% | 181 |
|
|
2014
Q3 | $605K | Sell |
16,426
-1,410
| -8% | -$50.9K | ﹤0.01% | 256 |
|
|
2014
Q2 | $697K | Buy |
17,836
+456
| +3% | +$16.9K | 0.01% | 210 |
|
|
2014
Q1 | $655K | Buy |
17,380
+6,102
| +54% | +$213K | 0.01% | 174 |
|
|
2013
Q4 | $338K | Buy |
11,278
+5,460
| +94% | +$209K | ﹤0.01% | 551 |
|
|
2013
Q3 | $252K | Buy |
+5,818
| New | +$233K | ﹤0.01% | 391 |
|
Other funds holding USNA
ALPS Advisors's USNA Position: Q1 2022 in Review
ALPS Advisors sold out of Usana Health Sciences (USNA) in Q1 2022, closing a stake of 4,045 shares — an estimated $409K sold.
ALPS Advisors first reported a position in USNA in Q3 2013 and held it in 28 quarters. The position peaked at $743K in Q4 2014. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.
- ALPS Advisors reported no remaining Usana Health Sciences position as of Q1 2022 after selling out during the quarter.
- ALPS Advisors sold 4,045 Usana Health Sciences shares in Q1 2022, an estimated $409K.
- ALPS Advisors first reported a position in Usana Health Sciences in Q3 2013 and held it in 28 quarters.
- ALPS Advisors's Usana Health Sciences position peaked at $743K in Q4 2014.
- 179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.
Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.